914348-80-4

Usage

Uses

Used in Pharmaceutical Research:
2-(4-(trifluoromethyl)phenyl)thiazole-5-carbaldehyde is utilized as a chemical intermediate in the synthesis of various pharmaceutical compounds. Its unique structure allows for the development of new drugs with potential therapeutic benefits.
Used in Drug Discovery:
In the field of drug discovery, 2-(4-(trifluoromethyl)phenyl)thiazole-5-carbaldehyde serves as a lead compound for the identification and optimization of new therapeutic agents. Its distinct chemical features facilitate the exploration of novel drug targets and mechanisms of action.
Used in Medicinal Chemistry:
2-(4-(trifluoromethyl)phenyl)thiazole-5-carbaldehyde is employed as a building block in medicinal chemistry for the design and synthesis of bioactive molecules. Its versatile chemical properties enable the creation of diverse chemical libraries for high-throughput screening and lead optimization.
Used in Chemical Synthesis:
2-(4-(trifluoromethyl)phenyl)thiazole-5-carbaldehyde is used as a reagent in various chemical synthesis processes. Its carbaldehyde functional group allows for a range of chemical reactions, enabling the preparation of complex organic molecules with potential applications in different industries.

InChI:InChI=1/C10H6FNOS/c11-8-3-1-7(2-4-8)10-12-5-9(6-13)14-10/h1-6H

Upstream product

• 68-12-2 N,N-dimethyl-formamide 
• 1005196-13-3 2-(4-fluorophenyl)thiazole 
• 1765-93-1 4-fluoroboronic acid 
• 464192-28-7 2-bromo-1,3-thiazole-5-carbaldehyde 

Downstream Products

• 1429330-22-2 1-(2-(4-fluorophenyl)thiazol-5-yl)-1-(pyridin-4-yl)ethyl acetate 
• 1226001-23-5 1-(2-(4-fluorophenyl)thiazol-5-yl)ethanone 
• 1429330-25-5 1-(2-(4-fluorophenyl)thiazol-5-yl)-1-(pyridin-4-yl)ethanamine 
• 1429330-26-6 N-(1-(2-(4-fluorophenyl)thiazol-5-yl)-1-(pyridin-4-yl)ethyl)acetamide 
• 1429329-63-4 1-(2-(4-fluorophenyl)thiazol-5-yl)-1-(pyridin-4-yl)ethanol 
• 1248685-91-7 1-(2-(4-fluorophenyl)thiazol-5-yl)ethanol 
• 1620546-00-0 C₂₄H₁₂BrClF₂N₂OS 
• 1620546-01-1 C₃₀H₂₄BClF₂N₂O₃S 
• 1620546-02-2 C₃₈H₃₃ClF₂N₆O₄S 
• 1620544-87-7 C₅₂H₅₄F₂N₁₀O₇S 
• 1620545-99-4 C₂₄H₁₄BrClF₂N₂OS 
• 1613081-63-2 C₅₂H₅₄F₂N₁₀O₇S 
• 1620546-02-2 C₃₈H₃₃ClF₂N₆O₄S 

Relevant academic research and scientific papers

HETEROCYCLE-SUBSTITUED TETRACYCLIC COMPOUNDS AND METHODS OF USE THEREOF FOR TREATMENT OF VIRAL DISEASES

The present invention relates to novel Heterocycle-Substituted Tetracyclic Compounds of Formula (I): (I) and pharmaceutically acceptable salts thereof, wherein A, A', R 2 R 3, R 4 and R are as defined herein. The present i

THIAZOLYL-SUBSTITUED TETRACYCLIC COMPOUNDS AND METHODS OF USE THEREOF FOR TREATMENT OF VIRAL DISEASES

The present invention relates to novel Thiazolyl-Substituted Tetracyclic Compounds of Formula (I) and pharmaceutically acceptable salts thereof, wherein A, A', R2R3, R4 and R5 are as defined herein. The present

PYRIDINE DERIVATIVES

The present application provides novel pyridine compounds and pharmaceutically acceptable salts or prodrugs thereof. Also provided are methods for preparing these compounds. These compounds are useful in inhibiting CYP 17 activity by administering a therapeutically effective amount of one or more of the compounds to a patient. By doing so, these compounds are effective in treating conditions associated with CPY17 activity. A variety of conditions can be treated using these compounds and include diseases which are characterized by abnormal cellular proliferation. In one embodiment, the disease is cancer, such as prostate cancer.

PIPERIDINE-CONTAINING COMPOUNDS AND USE THEREOF

A method for preventing and/or treating a metabolic disease, cerebrovascular disease, etc. which comprises administering to a mammal an effective amount of the compound of the formula (I) wherein all symbols have the same meanings as defined in the specification; a salt thereof, an N-oxide thereof, a solvate thereof, or a prodrug thereof. And a novel compound of the formula (I-1): wherein all symbols have the same meanings as defined in the specification; a salt thereof, an N-oxide thereof, a solvate thereof, or a prodrug thereof has an anti-diabetic effect and a neuroprotective effect. Accordingly, the compound of the formula (I) and the compound of the formula (I-1) are useful in a method for preventing and/or treating for a metabolic disease such as diabetes, cerebrovascular disease such as stroke, etc.